Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Online

Post-Marketing Safety Management

Increase your understanding about safety monitoring requirements for drugs after they are approved for marketing.

Authors

Mary  Mease, MPH, RPh

Mary Mease, MPH, RPh

PV and Risk Management Strategy and Operations, Consultant, United States

Ms. Mease leads safety and REMS at Quintiles. She served as an expert for 11 yrs at the FDA/CDER on drug benefit risk communication, risk management, and pharmacovigilance and led the establishment of CDER’s Drug Safety Oversight Board. She holds a BS in Pharmacy and a Masters in Public Health.

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.